Cancer
ROCHESTER, Minn. — A genomic test co-developed by Mayo Clinic and SkylineDx can identify whether people with melanoma are at low or high risk for[...]
Latest stories
Research
September 3, 2024
Cardiovascular
September 3, 2024
Individualized Medicine
August 29, 2024
Health & Wellness
August 17, 2024
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community